Merck stock reversed higher Thursday, though the company reported another quarter of light sales for its human papillomavirus vaccine, Gardasil. Gardasil sales plummeted 41% to $1.33 billion, widely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback